TAX incentives for researchers are making clinical trials in Australia up to 60% more cost-effective, according to a new report by Frost & Sullivan, which estimates the clinical trials market is growing at an annual rate of 12% and will be valued at $615m by 2019.
To view the report CLICK HERE.
Vital roles and contributions in healthcare made by outstanding pharmacists recognised. Last night in Perth, the…
MONTU Group, its subsidiary Alternaleaf Pty Ltd, and their common director Christopher Strauch are facing legal action by the Therapeutic Goods Administration (TGA) in the Federal Court of Australia for alleged unlawful advertising on the effectiveness of their medicinal cannabis products.
AUSTRALIA’S public hospitals are facing their lengthiest wait times on record for planned surgeries, with emergency departments struggling under access blockages, according to the latest annual Public Hospital Report Card by the Australian Medical Association (AMA).